[go: up one dir, main page]

MX2013005430A - Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario. - Google Patents

Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario.

Info

Publication number
MX2013005430A
MX2013005430A MX2013005430A MX2013005430A MX2013005430A MX 2013005430 A MX2013005430 A MX 2013005430A MX 2013005430 A MX2013005430 A MX 2013005430A MX 2013005430 A MX2013005430 A MX 2013005430A MX 2013005430 A MX2013005430 A MX 2013005430A
Authority
MX
Mexico
Prior art keywords
contained
user
delivery system
drug delivery
iontophoretic drug
Prior art date
Application number
MX2013005430A
Other languages
English (en)
Other versions
MX336812B (es
Inventor
Terri B Sebree
Robert P Stathopulos
Mihai A Vinatoru
Original Assignee
Nupathe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nupathe Inc filed Critical Nupathe Inc
Publication of MX2013005430A publication Critical patent/MX2013005430A/es
Publication of MX336812B publication Critical patent/MX336812B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describe un sistema activado por el usuario auto-contenido co-empacado iontoforético de suministro de fármaco y el método de uso para el tratamiento de un sujeto.
MX2013005430A 2010-11-23 2011-11-09 Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario. MX336812B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41662310P 2010-11-23 2010-11-23
PCT/US2011/059981 WO2012071175A1 (en) 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system

Publications (2)

Publication Number Publication Date
MX2013005430A true MX2013005430A (es) 2013-07-05
MX336812B MX336812B (es) 2016-02-02

Family

ID=45044724

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013005430A MX336812B (es) 2010-11-23 2011-11-09 Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario.

Country Status (12)

Country Link
US (1) US9327114B2 (es)
EP (1) EP2643048A1 (es)
JP (1) JP2013543773A (es)
CN (1) CN103228318B (es)
AU (1) AU2011332187B2 (es)
BR (1) BR112013012117A8 (es)
CA (1) CA2817824A1 (es)
EA (1) EA026254B1 (es)
IL (1) IL226067A0 (es)
MX (1) MX336812B (es)
NZ (1) NZ610305A (es)
WO (1) WO2012071175A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013012117A8 (pt) 2010-11-23 2017-10-10 Nupathe Inc Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
CA2916183C (en) 2013-07-03 2022-03-29 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with electronic component
EP2886153A1 (de) 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
CA2948221C (en) 2014-05-20 2022-11-22 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
WO2015177204A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system containing rotigotine
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
JP2016002368A (ja) * 2014-06-18 2016-01-12 日本電信電話株式会社 経皮薬物送達システム
WO2018006069A1 (en) 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
EP3788954B1 (en) * 2019-09-06 2022-04-13 SmartMedics Sp. z o.o. Layer structure with local reservoir
FR3152229A1 (fr) * 2023-08-25 2025-02-28 Feeligreen Dispositif de traitement de la peau

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US5042975A (en) 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4917676A (en) 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
DE3903794A1 (de) 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
US5499967A (en) 1992-02-27 1996-03-19 Societe Anonyme Dite: Laboratoires D'hygiene Societe Anonyme Dite: Et De Dietetique (L.H.D.) Transdermal drug delivery device with waveshape generator
FR2688106B1 (fr) 1992-02-27 1994-09-09 Lhd Lab Hygiene Dietetique Dispositif de generation d'une tension electrique de forme d'onde predeterminee, appareil ionophoretique d'administration transdermique de medicaments.
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
FI944321A7 (fi) 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseks i
US5445609A (en) 1993-05-28 1995-08-29 Alza Corporation Electrotransport agent delivery device having a disposable component and a removable liner
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
JPH08155041A (ja) 1994-12-05 1996-06-18 Advance Co Ltd イオントフォレシス用新規高能率電極システム
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
CA2208132A1 (en) 1994-12-21 1996-06-27 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5879322A (en) 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
IE960375A1 (en) 1995-06-05 1996-12-11 Alza Corp Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5983130A (en) 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
AU696832B2 (en) 1995-08-31 1998-09-17 Hisamitsu Pharmaceutical Co., Inc. Iontophoresis system and its control process of current
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5738647A (en) 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
US20010009983A1 (en) 1997-09-29 2001-07-26 Drug Delivery Technologies, Inc. Methods for implementing current delivery profiles used in an iontophoretic system
WO1999030773A1 (en) 1997-12-16 1999-06-24 Alza Corporation Regulator with artificial load to maintain regulated delivery
PT1047475E (pt) 1997-12-17 2007-04-30 Alza Corp Ionoforese com ajuste programado de corrente eléctrica
CA2367485A1 (en) 1999-04-12 2000-10-19 Hisamitsu Pharmaceuticals Co., Inc. Device for iontophoresis
US6385488B1 (en) 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6377848B1 (en) 1999-08-25 2002-04-23 Vyteris, Inc. Devices activating an iontophoretic delivery device
WO2003032983A1 (en) 2001-06-05 2003-04-24 Ronald Aung-Din Transdermal migraine therapy
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
WO2006133101A2 (en) 2005-06-03 2006-12-14 Trans-Dermal Patents Company, Llc Agent delivery system
US20090005824A1 (en) * 2007-06-29 2009-01-01 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
NZ622157A (en) * 2008-12-30 2015-10-30 Teva Pharmaceuticals Int Gmbh Electronic control of drug delivery system
BR112013012117A8 (pt) 2010-11-23 2017-10-10 Nupathe Inc Sistema de distribuição de fármaco iontoforético coempacotado de utilização única coempacotado autocontido, usos de fármaco e de composto de triptano

Also Published As

Publication number Publication date
US20130296766A1 (en) 2013-11-07
EP2643048A1 (en) 2013-10-02
EA201390745A1 (ru) 2014-01-30
WO2012071175A1 (en) 2012-05-31
EA026254B1 (ru) 2017-03-31
AU2011332187B2 (en) 2016-03-03
MX336812B (es) 2016-02-02
AU2011332187A1 (en) 2013-05-02
IL226067A0 (en) 2013-06-27
BR112013012117A2 (pt) 2016-09-27
CN103228318A (zh) 2013-07-31
US9327114B2 (en) 2016-05-03
CA2817824A1 (en) 2012-05-31
BR112013012117A8 (pt) 2017-10-10
JP2013543773A (ja) 2013-12-09
NZ610305A (en) 2015-10-30
CN103228318B (zh) 2016-03-23

Similar Documents

Publication Publication Date Title
MX2013005430A (es) Sistema de suministro de farmaco iontoforetico co - empacado auto - contenido activado por el usuario.
EP2782631A4 (en) IMPLANTABLE APPARATUS FOR USE IN THE ADMINISTRATION OF A SOLID-LIQUID MEDICAMENT, ASSOCIATED FORMULATIONS AND METHODS OF USE
EP2688639A4 (en) SYSTEM AND METHOD FOR THE TWO-PHASE TRANSDERMAL IONTOPHORETIC DELIVERY OF THERAPY AGENTS
MX2014004644A (es) Macrociclos peptidomimeticos.
EA033374B9 (ru) Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
PH12014501844B1 (en) Peptidomimetic macrocycles
EP2903506A4 (en) System and method for providing patient care
EP2814444A4 (en) ADMINISTRATION OF AUDIO AND TOUCH STIMULATION THERAPY FOR ANIMALS AND HUMANS
ZA201306573B (en) Transcutaneous stimulation method and system
ZA201303965B (en) Transdermal therapeutic system for administering an active substance
MY158992A (en) Forms of rifaximin and uses thereof
CY1124331T1 (el) Αυξημενη βιοδιαθεσιμοτητα δραστικης ουσιας σε θεραπεια ναλτρεξονης
EP2720748A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM AND METHOD OF USE THEREOF
IN2014DN11201A (es)
WO2011146699A3 (en) Nanochanneled device and related methods
IL254446A0 (en) Implantable drug delivery preparations and treatment methods thereof
GB201302925D0 (en) Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
EP2763716A4 (en) SOLID MEDICATION ADMINISTRATION APPARATUS, FORMULATIONS AND METHODS OF USE
PH12014502065A1 (en) Vesicular formulations
MX2010006019A (es) Metodos para administrar acido ribonucleico pequeño de interferencia (arnsi) mediante iontoforesis.
EP2578236A4 (en) PREPARATION OF MICROVESICULE-SIRNA COMPLEXES AND USE OF THOSE COMPLEXES IN THE TREATMENT OF AIDS
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
ZA201207189B (en) Tuberculosis drug based on 4-thioureido-iminomethlypyridinium perchlorate:method of preparation and treatment
HK1190106A (en) User-activated self-contained co-packaged iontophoretic drug delivery system
UA94830C2 (ru) Способ получения биологически активных веществ из желчи животных

Legal Events

Date Code Title Description
FG Grant or registration